Literature DB >> 11752608

Control of T helper cell differentiation--in search of master genes.

C Dong1, R A Flavell.   

Abstract

Naïve T helper (T(H)0) cells can differentiate into one of two distinct populations: T(H)1 and T(H)2. Each population is characterized by the expression of specific cytokines and their ability to participate in cell-mediated or humoral immune responses. Recent efforts at identifying the molecular mechanisms through which T(H)0 cells become T(H)1 or T(H)2 cells have been promising. A number of transcription factors, including GATA-3 and T-bet, have been identified that promote the differentiation of T(H)0 cells and the maintenance of the differentiated cell phenotype. Dong and Flavell review recent findings on proteins that control the fate of T(H)0 differentiation, whether by promotion or inhibition, and discuss the role of epigenesis in the differentiation process.

Entities:  

Mesh:

Year:  2000        PMID: 11752608     DOI: 10.1126/stke.2000.49.pe1

Source DB:  PubMed          Journal:  Sci STKE        ISSN: 1525-8882


  23 in total

Review 1.  PKC-θ is a drug target for prevention of T cell-mediated autoimmunity and allograft rejection.

Authors:  Myung-Ja Kwon; Ruiqing Wang; Jian Ma; Zuoming Sun
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-12       Impact factor: 2.895

Review 2.  Cell-mediated adaptive immune defense of the lungs.

Authors:  Jeffrey L Curtis
Journal:  Proc Am Thorac Soc       Date:  2005

3.  T cells expanded in presence of IL-15 exhibit increased antioxidant capacity and innate effector molecules.

Authors:  Navtej Kaur; Osama S Naga; Håkan Norell; Amir A Al-Khami; Matthew J Scheffel; Nitya G Chakraborty; Christina Voelkel-Johnson; Bijay Mukherji; Shikhar Mehrotra
Journal:  Cytokine       Date:  2011-05-23       Impact factor: 3.861

Review 4.  IL-4: an important cytokine in determining the fate of T cells.

Authors:  J L Silva-Filho; C Caruso-Neves; A A S Pinheiro
Journal:  Biophys Rev       Date:  2014-01-09

Review 5.  Phosphoinositide 3-kinase δ is a regulatory T-cell target in cancer immunotherapy.

Authors:  Ee Lyn Lim; Klaus Okkenhaug
Journal:  Immunology       Date:  2019-07       Impact factor: 7.397

Review 6.  Axotrophin and leukaemia inhibitory factor (LIF) in transplantation tolerance.

Authors:  Su M Metcalfe
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

7.  Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase.

Authors:  Jean S Oak; Jonathan A Deane; Michael G Kharas; Ji Luo; Thomas E Lane; Lewis C Cantley; David A Fruman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-27       Impact factor: 11.205

8.  Requirement for the basic helix-loop-helix transcription factor Dec2 in initial TH2 lineage commitment.

Authors:  Xuexian O Yang; Pornpimon Angkasekwinai; Jinfang Zhu; Juan Peng; Zhiduo Liu; Roza Nurieva; Xikui Liu; Yeonseok Chung; Seon Hee Chang; Bing Sun; Chen Dong
Journal:  Nat Immunol       Date:  2009-11-01       Impact factor: 25.606

9.  Natural killer receptors: the burden of a name.

Authors:  Henrique Veiga-Fernandes; Dimitris Kioussis; Mark Coles
Journal:  J Exp Med       Date:  2010-02-08       Impact factor: 14.307

10.  Vaccination of mice with salmonella expressing VapA: mucosal and systemic Th1 responses provide protection against Rhodococcus equi infection.

Authors:  Aline F Oliveira; Luciana P Ruas; Silvia A Cardoso; Sandro G Soares; Maria-Cristina Roque-Barreira
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.